170 related articles for article (PubMed ID: 25789374)
1. Use of next-generation DNA sequencing to analyze genetic variants in rheumatic disease.
Wiley GB; Kelly JA; Gaffney PM
Arthritis Res Ther; 2014; 16(6):490. PubMed ID: 25789374
[TBL] [Abstract][Full Text] [Related]
2. Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes.
Lotta LA; Wang M; Yu J; Martinelli I; Yu F; Passamonti SM; Consonni D; Pappalardo E; Menegatti M; Scherer SE; Lewis LL; Akbar H; Wu Y; Bainbridge MN; Muzny DM; Mannucci PM; Gibbs RA; Peyvandi F
BMC Med Genomics; 2012 Feb; 5():7. PubMed ID: 22353194
[TBL] [Abstract][Full Text] [Related]
3. Insights into rheumatic diseases from next-generation sequencing.
Donlin LT; Park SH; Giannopoulou E; Ivovic A; Park-Min KH; Siegel RM; Ivashkiv LB
Nat Rev Rheumatol; 2019 Jun; 15(6):327-339. PubMed ID: 31000790
[TBL] [Abstract][Full Text] [Related]
4. Genome editing to define the function of risk loci and variants in rheumatic disease.
Baglaenko Y; Macfarlane D; Marson A; Nigrovic PA; Raychaudhuri S
Nat Rev Rheumatol; 2021 Aug; 17(8):462-474. PubMed ID: 34188205
[TBL] [Abstract][Full Text] [Related]
5. Fine-mapping the human leukocyte antigen locus in rheumatoid arthritis and other rheumatic diseases: identifying causal amino acid variants?
van Heemst J; Huizinga TJ; van der Woude D; Toes RE
Curr Opin Rheumatol; 2015 May; 27(3):256-61. PubMed ID: 25760279
[TBL] [Abstract][Full Text] [Related]
6. Genetics, genomics, and their relevance to pathology and therapy.
Ombrello MJ; Sikora KA; Kastner DL
Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):175-89. PubMed ID: 24974057
[TBL] [Abstract][Full Text] [Related]
7. Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases.
Sparks JA; Costenbader KH
Rheum Dis Clin North Am; 2014 Nov; 40(4):637-57. PubMed ID: 25437282
[TBL] [Abstract][Full Text] [Related]
8. The genetics revolution in rheumatology: large scale genomic arrays and genetic mapping.
Eyre S; Orozco G; Worthington J
Nat Rev Rheumatol; 2017 Jul; 13(7):421-432. PubMed ID: 28569263
[TBL] [Abstract][Full Text] [Related]
9. Genetically transitional disease: conceptual understanding and applicability to rheumatic disease.
Niewold TB; Aksentijevich I; Gorevic PD; Gibson G; Yao Q
Nat Rev Rheumatol; 2024 May; 20(5):301-310. PubMed ID: 38418715
[TBL] [Abstract][Full Text] [Related]
10. Use of RNA sequencing to evaluate rheumatic disease patients.
Giannopoulou EG; Elemento O; Ivashkiv LB
Arthritis Res Ther; 2015 Jul; 17(1):167. PubMed ID: 26126608
[TBL] [Abstract][Full Text] [Related]
11. Integrative Approaches to Understanding the Pathogenic Role of Genetic Variation in Rheumatic Diseases.
Laufer VA; Chen JY; Langefeld CD; Bridges SL
Rheum Dis Clin North Am; 2017 Aug; 43(3):449-466. PubMed ID: 28711145
[TBL] [Abstract][Full Text] [Related]
12. Future Directions of Genomics Research in Rheumatic Diseases.
Okada Y; Kishikawa T; Sakaue S; Hirata J
Rheum Dis Clin North Am; 2017 Aug; 43(3):481-487. PubMed ID: 28711147
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic-based immune intervention for rheumatic diseases.
Gray SG
Epigenomics; 2014 Apr; 6(2):253-71. PubMed ID: 24811793
[TBL] [Abstract][Full Text] [Related]
14. [Genetic methods for analysis of autoinflammatory diseases].
Bienias M; König N; Wolf C; Kretschmer S; Rösen-Wolff A; Berner R; Tüngler V; Lee-Kirsch MA
Z Rheumatol; 2017 May; 76(4):295-302. PubMed ID: 28378116
[TBL] [Abstract][Full Text] [Related]
15. Strategies using functional genomics in rheumatic diseases.
Burmester GR; Häupl T
Autoimmun Rev; 2004 Nov; 3(7-8):541-9. PubMed ID: 15546803
[TBL] [Abstract][Full Text] [Related]
16. Mapping susceptibility gene in systemic lupus erythematosus.
Scofield RH; Kaufman KM
Methods Mol Biol; 2012; 900():11-24. PubMed ID: 22933063
[TBL] [Abstract][Full Text] [Related]
17. Genetics of rheumatic disease.
Clarke A; Vyse TJ
Arthritis Res Ther; 2009; 11(5):248. PubMed ID: 19849816
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the genetic determinants of hemostasis and thrombosis.
Desch KC
Curr Opin Hematol; 2015 Sep; 22(5):428-36. PubMed ID: 26248003
[TBL] [Abstract][Full Text] [Related]
19. Pooled-DNA Sequencing for Elucidating New Genomic Risk Factors, Rare Variants Underlying Alzheimer's Disease.
Jin SC; Benitez BA; Deming Y; Cruchaga C
Methods Mol Biol; 2016; 1303():299-314. PubMed ID: 26235075
[TBL] [Abstract][Full Text] [Related]
20. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
